22157.jpg
Hepatitis A Therapeutics Market Research 2024: Comprehensive Insights about 3+ Companies and 3+ Pipeline Drugs Featuring Boryung Pharma, Cadila Healthcare, Indian Immunologicals, & Biological E
July 25, 2024 07:47 ET | Research and Markets
Dublin, July 25, 2024 (GLOBE NEWSWIRE) -- The "Hepatitis A - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Hepatitis A - Pipeline Insight, 2024,"...
22157.jpg
Hepatitis D Therapeutics Market Research 2024: Comprehensive Insights about 6+ Companies and 6+ Pipeline Drugs
July 23, 2024 09:53 ET | Research and Markets
Dublin, July 23, 2024 (GLOBE NEWSWIRE) -- The "Hepatitis D - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights...
Global Anti-Infectives Market
$230+ Bn Anti-Infectives Markets - Global Strategic Business Report to 2030: Telemedicine and Digital Health Platforms Drives Adoption, Rising Prevalence of Drug-Resistant Infections Spurs Innovation
July 22, 2024 09:15 ET | Research and Markets
Dublin, July 22, 2024 (GLOBE NEWSWIRE) -- The "Anti-Infectives - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Anti-Infectives...
Global Herpes Simplex Virus Infections Market
$6.6 Bn Herpes Simplex Virus Infections Markets - Global Strategic Business Report to 2030 with Coverage of 10+ Major Players Including Admedus, Agenus, and Aicuris Anti-infective Cures
July 19, 2024 08:50 ET | Research and Markets
Dublin, July 19, 2024 (GLOBE NEWSWIRE) -- The "Herpes Simplex Virus Infections - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
22157.jpg
Chagas Disease Therapeutic Assessment 2024: Comprehensive Insights About 5+ Companies and 5+ Pipeline Drugs
July 17, 2024 10:10 ET | Research and Markets
Dublin, July 17, 2024 (GLOBE NEWSWIRE) -- The "Chagas disease - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
22157.jpg
Cytomegalovirus Infection Therapeutics Research 2024: Comprehensive Insights About 15+ Companies and 20+ Pipeline Drugs Featuring Vir, SpyBiotech, Moderna, VBI, Trellis Bioscience, GSK, & AlloVir
July 03, 2024 04:10 ET | Research and Markets
Dublin, July 03, 2024 (GLOBE NEWSWIRE) -- The "Cytomegalovirus Infection - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Cytomegalovirus...
22157.jpg
Respiratory Syncytial Virus (RSV) Infections Global Clinical Trials Review 2024: Region, Country (G7 & E7), Phase, Trial Status, End Points Status and Sponsor Type
July 01, 2024 09:52 ET | Research and Markets
Dublin, July 01, 2024 (GLOBE NEWSWIRE) -- The "Respiratory Syncytial Virus (RSV) Infections - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's...
22157.jpg
Ceftriaxone Industry Research 2024: Effective Treatment of Multi-Drug Resistant Infections Bolsters Growth - Global Forecasts to 2032
June 28, 2024 11:31 ET | Research and Markets
Dublin, June 28, 2024 (GLOBE NEWSWIRE) -- The "Global Ceftriaxone Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts,...
22157.jpg
Innovative Progress in BK Virus (BKV) Infection Pipeline: 2024 Drug Insights - Therapeutic Assessment and Opportunities
June 18, 2024 10:11 ET | Research and Markets
Dublin, June 18, 2024 (GLOBE NEWSWIRE) -- The "BK Virus (BKV) Infection - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.The medical community hails the...
22157.jpg
Chlamydia Pipeline Landscape Research 2024: Therapeutic Assessment of 5+ Companies and 5+ Pipeline Drugs by Type, Stage, Route of Administration, and Molecule
June 17, 2024 07:26 ET | Research and Markets
Dublin, June 17, 2024 (GLOBE NEWSWIRE) -- The "Chlamydia - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This "Chlamydia- Pipeline Insight, 2024" report...